These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 18081510
1. High altitude and retinal detachment. Morris DS, Severn PS, Smith J, Somner JE, Stannard KP, Cottrell DG. High Alt Med Biol; 2007; 8(4):337-9. PubMed ID: 18081510 [Abstract] [Full Text] [Related]
2. Findings of Cognitive Impairment at High Altitude: Relationships to Acetazolamide Use and Acute Mountain Sickness. Phillips L, Basnyat B, Chang Y, Swenson ER, Harris NS. High Alt Med Biol; 2017 Jun; 18(2):121-127. PubMed ID: 28509579 [Abstract] [Full Text] [Related]
3. Acetazolamide Use in an Ultra-Runner: A Complicated Treatment Consideration for AMS. Biondich AS, Joslin JD. Wilderness Environ Med; 2016 Mar; 27(1):179-80. PubMed ID: 26520404 [No Abstract] [Full Text] [Related]
4. Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial. Basnyat B, Gertsch JH, Holck PS, Johnson EW, Luks AM, Donham BP, Fleischman RJ, Gowder DW, Hawksworth JS, Jensen BT, Kleiman RJ, Loveridge AH, Lundeen EB, Newman SL, Noboa JA, Miegs DP, O'Beirne KA, Philpot KB, Schultz MN, Valente MC, Wiebers MR, Swenson ER. High Alt Med Biol; 2006 Mar; 7(1):17-27. PubMed ID: 16544963 [Abstract] [Full Text] [Related]
5. Acetazolamide and sulfa allergy: how to deal with sulfa allergy at altitude? Kurdziel M. Pol Arch Med Wewn; 2013 Mar; 123(9):504-5. PubMed ID: 24084254 [No Abstract] [Full Text] [Related]
6. Tadalafil and acetazolamide versus acetazolamide for the prevention of severe high-altitude illness. Leshem E, Caine Y, Rosenberg E, Maaravi Y, Hermesh H, Schwartz E. J Travel Med; 2012 Mar; 19(5):308-10. PubMed ID: 22943271 [Abstract] [Full Text] [Related]
7. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness. van Patot MC, Leadbetter G, Keyes LE, Maakestad KM, Olson S, Hackett PH. High Alt Med Biol; 2008 Mar; 9(4):289-93. PubMed ID: 19115912 [Abstract] [Full Text] [Related]
10. Age is no barrier to success at very high altitudes. Stokes S, Kalson NS, Earl M, Whitehead AG, Tyrrell-Marsh I, Frost H, Davies A. Age Ageing; 2010 Mar; 39(2):262-5. PubMed ID: 20068217 [No Abstract] [Full Text] [Related]
11. Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis. Low EV, Avery AJ, Gupta V, Schedlbauer A, Grocott MP. BMJ; 2012 Oct 18; 345():e6779. PubMed ID: 23081689 [Abstract] [Full Text] [Related]
12. Acetazolamide or not, prior to ascent? DeLellis SM. J Spec Oper Med; 2010 Oct 18; 10(4):38-40. PubMed ID: 21442590 [Abstract] [Full Text] [Related]
13. Reduced Acetazolamide Dosing in Countering Altitude Illness: A Comparison of 62.5 vs 125 mg (the RADICAL Trial). McIntosh SE, Hemphill M, McDevitt MC, Gurung TY, Ghale M, Knott JR, Thapa GB, Basnyat B, Dow J, Weber DC, K Grissom C. Wilderness Environ Med; 2019 Mar 18; 30(1):12-21. PubMed ID: 30630671 [Abstract] [Full Text] [Related]
15. A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet (3630 m). Carlsten C, Swenson ER, Ruoss S. High Alt Med Biol; 2004 Mar 18; 5(1):33-9. PubMed ID: 15072715 [Abstract] [Full Text] [Related]
16. Acetazolamide-induced myopia at altitude. Szawarski P, Hall-Thompson B. Wilderness Environ Med; 2009 Mar 18; 20(3):300-1. PubMed ID: 19737035 [No Abstract] [Full Text] [Related]
17. Efficacy of low-dose acetazolamide for the prophylaxis of acute mountain sickness. Dumont L, Tramer MR, Lysakowski C, Mardirosoff C, Kayser B. High Alt Med Biol; 2003 Mar 18; 4(3):399; author reply 400. PubMed ID: 14561245 [No Abstract] [Full Text] [Related]